Hutchmed Roils Markets With Changing of Its Guard, U.S. Delisting Threat
人事变动叠加退市警告，和黄医药“祸不单行”

U.S. securities regulator singles out company for potential delisting, a week after Hutchmed announced its CEO will step down after almost 22 years.
和黄医药履职22年的首席执行官即将退休，该消息宣布一周后，美国证券监管机构将其列为可能退市的公司之一。